MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, D.
Right arrow Articles by Benjamin, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, D.
Right arrow Articles by Benjamin, T.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2004, p. 3885-3893, Vol. 24, No. 9
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.9.3885-3893.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

p150Sal2 Is a p53-Independent Regulator of p21WAF1/CIP

Dawei Li, Yu Tian, Yupo Ma, and Thomas Benjamin*

Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Received 5 September 2003/ Returned for modification 26 September 2003/ Accepted 21 January 2004

p150Sal2, a vertebrate homologue of the Drosophila melanogaster homeotic transcription factor Spalt, has previously been shown to be a binding target of the polyomavirus large T antigen. p150Sal2 acts as an inhibitor of viral DNA synthesis, and the binding of p150Sal2 by large T overcomes this inhibition. The present study focuses on the effects of p150Sal2 on the growth and survival of ovarian carcinoma (OVCA) cells that are deficient in expression of p150Sal2 and of normal established human ovarian surface epithelial (HOSE) cells which abundantly express the protein. Transient expression of exogenous p150Sal2 in OVCA cells that show little or no endogenous expression resulted in inhibition of DNA synthesis and colony formation and in increased apoptosis. OVCA cells stably transfected and expressing physiological levels of p150Sal2 showed reduced tumorigenicity accompanied by increased expression of p21WAF1/CIP1 (p21) and BAX. Conversely, reduction of endogenous levels of p150Sal2 in HOSE resulted in reduced p21 expression and increased DNA synthesis. p150Sal2 bound to the p21 promoter adjacent to the known p53 binding sites and stimulated transcription in the absence of p53. We propose that p150Sal2, acting in part as a p53-independent regulator of p21 and BAX, can function in some cell types as a regulator of cell growth and survival.


* Corresponding author. Mailing address: Department of Pathology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-1960. Fax: (617) 432-2689. E-mail: tbenjamin{at}hms.harvard.edu.


Molecular and Cellular Biology, May 2004, p. 3885-3893, Vol. 24, No. 9
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.9.3885-3893.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.